Get the Stockscreener App
17.56
2.61%
-0.47
Mediwound Ltd stock is traded at $17.56, with a volume of 37,380.
It is down -2.61% in the last 24 hours and up +0.11% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$18.03
Open:
$17.91
24h Volume:
37,380
Relative Volume:
0.38
Market Cap:
$189.78M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-12.72
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
-4.20%
1M Performance:
+0.11%
6M Performance:
-1.68%
1Y Performance:
+4.59%
1-Day Range:
$17.54
$18.00
1-Week Range:
$17.50
$18.58
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.56 | 231.17M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
Discipline and Rules-Based Execution in MDWD Response - news.stocktradersdaily.com
Using R and stats models for MediWound Ltd. forecastingMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com
Will MediWound Ltd. stock maintain growth story2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
MediWound Ltd. (NASDAQ:MDWD) Receives $32.25 Average PT from Analysts - Defense World
Combining price and volume data for MediWound Ltd.2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Is Buying Stock In MediWound Ltd (MDWD) A Good Move Today? - fostersleader.com
Visualizing MediWound Ltd. stock with heatmapsWeekly Stock Analysis & Weekly Top Gainers Trade List - newser.com
Is MediWound Ltd. stock positioned for digital transformationTake Profit & Low Drawdown Investment Ideas - newser.com
When is the best time to exit MediWound Ltd.Quarterly Trade Report & High Accuracy Swing Trade Signals - newser.com
Is MediWound Ltd. stock gaining market share2025 Key Lessons & Weekly Breakout Stock Alerts - newser.com
Will a bounce in MediWound Ltd. offer an exitPortfolio Risk Summary & High Win Rate Trade Tips - newser.com
Risk Off: Will MediWound Ltd. stock maintain growth storyTrade Risk Report & Stepwise Trade Execution Plans - fcp.pa.gov.br
MediWound Ltd. Scheduled to Report Third Quarter 2025 Financial Results on November 20 - Quiver Quantitative
MediWound to Report Third Quarter 2025 Financial Results - The Manila Times
MediWound (NASDAQ: MDWD) sets results release Nov. 20 at 8:30 a.m. ET, conference call - Stock Titan
Rising Trends of U.S Wound Care Centers Market Generated - openPR.com
Is a relief rally coming for MediWound Ltd. holders2025 Market Overview & Verified High Yield Trade Plans - newser.com
MediWound Ltd. Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid - MarketScreener
MediWound Ltd. Announces Successful Commissioning of Expanded GMP Manufacturing Facility for NexoBrid® - Quiver Quantitative
U.S. Digital Wound Management Devices Market is Going to Boom: - openPR.com
Technical analysis overview for MediWound Ltd. stockWeekly Trade Recap & Daily Chart Pattern Signals - newser.com
Volume Report: Can MediWound Ltd. stock continue upward trendInsider Buying & Safe Swing Trade Setups - fcp.pa.gov.br
Is MediWound Ltd. stock a bargain at current levelsEarnings Recap Summary & Fast Entry Momentum Trade Alerts - newser.com
MediWound (NASDAQ:MDWD) Stock Price Crosses Above Fifty Day Moving AverageShould You Sell? - MarketBeat
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):